This project centres on KIR3DL1 polymorphism and how it translates to improved outcomes in hematopoietic stem cell transplantation for the treatment of haematological malignancy (Vivian et al. J. Exp. Med (2016)) Combining functional and clinical data, the aim is to understand KIR in donor selection for HSCT treatment of AML.
Immune receptors, Innate immunity, leukaemia
Biomedicine Discovery Institute (School of Biomedical Sciences) » Biochemistry and Molecular Biology